We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

ProSat - Effect of Probiotics on Satiety (ProSat)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00826761
First Posted: January 22, 2009
Last Update Posted: June 15, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Chr Hansen
Information provided by (Responsible Party):
AAstrup, University of Copenhagen
  Purpose
The aim of the ProSat study is to examine the effects of a probiotic capsule containing one of two doses (low and high dose) of Lb. Casei on subjective appetite sensation, ad libitum energy intake, and appetite hormone response in a single meal test and to determine whether the acute effects persist after daily supplementation of the probiotic capsule.

Condition Intervention
Obesity Appetite Regulation Dietary Supplement: probiotic Dietary Supplement: placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Probiotics and Satiety - Acute Effects and Persistence of Acute Effects

Further study details as provided by AAstrup, University of Copenhagen:

Primary Outcome Measures:
  • Glucose; Insulin; GLP-1; CCK; PYY; grehlin; PP; amylin; LPS; TNF-alfa; hsCRP; fibrinogen [ Time Frame: 2013 ]

Secondary Outcome Measures:
  • Subjective appetite measurements; Spontaneous food intake [ Time Frame: 2012 ]

Enrollment: 22
Study Start Date: January 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
High dose Lb. casei
Dietary Supplement: probiotic
One capsule per meal test (high dose or low dose)
Active Comparator: 2
Low dose Lb. Casei
Dietary Supplement: probiotic
One capsule per meal test (high dose or low dose)
Placebo Comparator: 3 Dietary Supplement: placebo
1 capsuel every morning

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy men and women
  • Normal to slight overweight (BMI: 22-28 kg/m2)
  • 20-45 years of age

Exclusion Criteria:

  • Smoking
  • Daily medicine use (oral contraceptives excluded)
  • Use of pre- and probiotic supplements and foods
  • Blood donation 3 months prior to the study
  • Hb<8mmol/l
  • Chronic illnesses such as hyperlipidemia, diabetes inflammatory diseases
  • Pregnancy or breastfeeding
  • Elite athletes (>10 hours hard exercise/week)
  • Vegetarians
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00826761


Locations
Denmark
Department of Human Nutrition
Frederiksberg, Denmark
Sponsors and Collaborators
University of Copenhagen
Chr Hansen
  More Information

Responsible Party: AAstrup, Professor, University of Copenhagen
ClinicalTrials.gov Identifier: NCT00826761     History of Changes
Other Study ID Numbers: B257
First Submitted: January 21, 2009
First Posted: January 22, 2009
Last Update Posted: June 15, 2012
Last Verified: June 2012